Vision, Retinal Thickness, and Foveal Avascular Zone Size After Intravitreal Bevacizumab for Diabetic Macular Edema

EROL N., Gursoy H. H., Kimyon S., Topbas S., ÇOLAK E.

ADVANCES IN THERAPY, cilt.29, sa.4, ss.359-369, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 4
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s12325-012-0009-9
  • Dergi Adı: ADVANCES IN THERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.359-369
  • Anahtar Kelimeler: Bevacizumab, Central macular thickness, Diabetic macular edema, Diabetic retinopathy, Foveal avascular zone, Intravitrealinjection, Visual acuity, VISUAL-ACUITY, AVASTIN, PHOTOCOAGULATION, RETINOPATHY, THERAPY, MICROCIRCULATION, IMPAIRMENT
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

To investigate three monthly intravitreal bevacizumab (IVB) injections effects in chronic diabetic macular edema (DME).